Registration - Organization
Cystic Fibrosis Canada / Kelly Grover, President and CEO
Registration Information
Senior Officer Name: Kelly Grover, President and CEO
Senior Officer Change History
Initial registration start date: 2016-05-04
Registration status: Active
Projected end date: No date provided
Registration number: 1476-1197
Version 16 of 16 (2024-12-03 to present)
Version 16 of 16 (2024-12-03 to present)
Lobbying Information
Details Regarding the Identified Subject Matter |
|||||||
Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below: | Yes | ||||||
|
BC Ministries/Provincial Entities
- Provincial Health Services Authority
Organization Details
Senior Officer Name and Position during the Period of this Registration
Kelly Grover, President and CEO
Organization Contact Information
Cystic Fibrosis Canada
Address:
2323 Yonge St.800
8th Floor
Toronto, ON M4P 2C9
Canada
Telephone number:
647-268-0237
Fax number:
416-485-5707
Description of Activities
Cystic Fibrosis Canada is a national charitable not-for-profit corporation established in 1960, and is one of the world's top three charitable organizations committed to finding a cure for cystic fibrosis (CF). As an internationally recognized leader in funding innovation and clinical care, we invest more in life-saving CF research and care than any other non-governmental agency in Canada.
Gifts or benefits provided by the organization
Name | Gift or Benefit Description | Circumstance | Date Promised | Value Promised | Date Given | Value Given |
---|---|---|---|---|---|---|
No Records |
Contributors to the Lobbying Activity
No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of the organization that has a direct interest in the outcome of the lobbying activity.
Government Funding in the Last 12 Months
Received Government Funding
The Received Government Funding table below is not intended to be additive. Adding all of the entries together does not necessarily provide an accurate sum of all government funding received. There may be redundancy (reporting of the same funding more than once) caused by overlap in the "Date/Period Received" between 2 or more entries.
Source of Government Funding | Funding Received | Date/Period Received |
---|---|---|
ESDC | $21,350.00 | 2023-01-01 to 2024-12-31 |
Coalition Members Information
Cystic Fibrosis Canada is not a coalition member.
Affiliates with a Direct Interest in the Outcome
Cystic Fibrosis Canada does not have any affiliates that could have a direct interest in the outcome of the lobbying activities
Other Persons or Organizations with Direct Interests
The activities of Cystic Fibrosis Canada are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.
Lobbyists Details
Lobbyist | Contributions | ||
---|---|---|---|
Paul Eckford Subscribes to a Code of Conduct: No Former Public Office Holder in BC: No |
|
||
Kelly Grover Subscribes to a Code of Conduct: No Former Public Office Holder in BC: No |
|
||
Jana Kocourek Subscribes to a Code of Conduct: No Former Public Office Holder in BC: No |
|
||
Kim Steele Subscribes to a Code of Conduct: No Former Public Office Holder in BC: No |
|
||
Christy Thomson Subscribes to a Code of Conduct: No Former Public Office Holder in BC: No |
|
- Date Modified: